Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Mar;47(3):595–605.

Disordered immunoregulatory functions in patients with chronic active hepatitis.

A Nonomura, M Tanino, H Kurumaya, G Ohta, Y Kato, K Kobayashi
PMCID: PMC1536421  PMID: 6211306

Abstract

Peripheral T lymphocytes from patients with chronic active hepatitis (CAH) showed a significantly decreased suppressor cell (or increased helper cell) effect on differentiation of allogenic B cells to Ig-producing cells (Ig-PC). Spontaneous helper cell activity as measured after irradiation of T cells appeared normal, while Concanavalin A (Con A)-induced suppressor cell activity was significantly reduced. Some patients of chronic persistent hepatitis (CPH) also showed mild depression of Con A-induced suppressor cell activity. Poor suppressor cell activity in CAH was much more often seen in HBsAg negative, autoantibody positive patients than in HBsAg positive autoantibody negative ones. Autologous mixed lymphocyte reaction (AMLR) was significantly decreased in patients with CAH. Also, a serum factor(s) that decreased Con A-induced suppressor cell function of healthy subjects could be demonstrated in some patients with CAH and CPH. Our results suggest that altered immune responses observed in CAH may be due to defective suppressor cell function, partly attributable to serum factor(s).

Full text

PDF
595

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdou N. I., Sagawa A., Pascual E., Hebert J., Sadeghee S. Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus. Clin Immunol Immunopathol. 1976 Sep;6(2):192–199. doi: 10.1016/0090-1229(76)90110-0. [DOI] [PubMed] [Google Scholar]
  2. Alberti A., Realdi G., Tremolada F., Spina G. P. Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis. Clin Exp Immunol. 1976 Sep;25(3):396–402. [PMC free article] [PubMed] [Google Scholar]
  3. Bean M. A., Kodera Y., Cummings K. B., Bloom B. R. Occurrence of restricted suppressor T-cell activity in man. J Exp Med. 1977 Nov 1;146(5):1455–1460. doi: 10.1084/jem.146.5.1455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bresnihan B., Jasin H. E. Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest. 1977 Jan;59(1):106–116. doi: 10.1172/JCI108607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Broder S., Poplack D., Whang-Peng J., Durm M., Goldman C., Muul L., Waldmann T. A. Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells. N Engl J Med. 1978 Jan 12;298(2):66–72. doi: 10.1056/NEJM197801122980202. [DOI] [PubMed] [Google Scholar]
  6. Colombo M., Vernace S. J., Paronetto F. T and B lymphocytes in patients with chronic active hepatitis (CAH). Clin Exp Immunol. 1977 Oct;30(1):4–9. [PMC free article] [PubMed] [Google Scholar]
  7. DeHoratius R. J., Strickland R. G., Williams R. C., Jr T and B lymphocytes in acute and chronic hepatitis. Clin Immunol Immunopathol. 1974 Apr;2(3):353–360. doi: 10.1016/0090-1229(74)90053-1. [DOI] [PubMed] [Google Scholar]
  8. Dehoratius R. J., Henderson C., Strickland R. G. Lymphocytotoxins in acute and chronic hepatitis. Characterization and relationship to changes in circulating T lymphocytes. Clin Exp Immunol. 1976 Oct;26(1):21–27. [PMC free article] [PubMed] [Google Scholar]
  9. Doniach D., Roitt I. M., Walker J. G., Sherlock S. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966 Jul;1(3):237–262. [PMC free article] [PubMed] [Google Scholar]
  10. Dutton R. W. Suppressor T cells. Transplant Rev. 1975;26:39–55. doi: 10.1111/j.1600-065x.1975.tb00174.x. [DOI] [PubMed] [Google Scholar]
  11. Eddleston A. L., Williams R. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet. 1974 Dec 28;2(7896):1543–1545. doi: 10.1016/s0140-6736(74)90287-6. [DOI] [PubMed] [Google Scholar]
  12. Gerber N. L., Hardin J. A., Chused T. M., Steinberg A. D. Loss with age in NZB-W mice of thymic suppressor cells in the graft-vs-host reaction. J Immunol. 1974 Nov;113(5):1618–1625. [PubMed] [Google Scholar]
  13. Gershon R. K. T cell control of antibody production. Contemp Top Immunobiol. 1974;3:1–40. doi: 10.1007/978-1-4684-3045-5_1. [DOI] [PubMed] [Google Scholar]
  14. Geubel A. P., Keller R. H., Summerskill W. H., Dickson E. R., Tomasi T. B., Shorter R. G. Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome. Gastroenterology. 1976 Sep;71(3):450–456. [PubMed] [Google Scholar]
  15. Giustino V., Dudley F. J., Sherlock S. Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen. Lancet. 1972 Oct 21;2(7782):850–853. doi: 10.1016/s0140-6736(72)92212-x. [DOI] [PubMed] [Google Scholar]
  16. Hodgson H. J., Wands J. R., Isselbacher K. J. Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol. 1978 Jun;32(3):451–458. [PMC free article] [PubMed] [Google Scholar]
  17. Horowitz S., Borcherding W., Moorthy A. V., Chesney R., Schulte-Wisserman H., Hong R. Induction of suppressor T cells in systemic lupus erythematosus by thymosin and cultured thymic epithelium. Science. 1977 Sep 2;197(4307):999–1001. doi: 10.1126/science.302032. [DOI] [PubMed] [Google Scholar]
  18. Innes J. B., Kuntz M. M., Kim Y. T., Weksler M. E. Induction of suppressor activity in the autologous mixed lymphocyte reaction and in cultures with concanavalin A. J Clin Invest. 1979 Dec;64(6):1608–1613. doi: 10.1172/JCI109622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jensen D. M., McFarlane I. G., Portmann B. S., Eddleston A. L., Williams R. Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med. 1978 Jul 6;299(1):1–7. doi: 10.1056/NEJM197807062990101. [DOI] [PubMed] [Google Scholar]
  20. Kakumu S., Arakawa Y., Goji H., Kashio T., Yata K. Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases. Gastroenterology. 1979 Apr;76(4):665–672. [PubMed] [Google Scholar]
  21. Kuntz M. M., Innes J. B., Weksler M. E. Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes. J Exp Med. 1976 May 1;143(5):1042–1054. doi: 10.1084/jem.143.5.1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Meyer zum Büschenfelde K. H., Hütteroth T. H., Arnold W., Hopf U. Immunologic liver injury: the role of hepatitis B viral antigens and liver membrane antigens as targets. Prog Liver Dis. 1979;6:407–424. [PubMed] [Google Scholar]
  23. Miller J., Smith M. G., Mitchell C. G., Reed W. D., Eddleston A. L., Williams R. Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet. 1972 Aug 12;2(7772):296–297. doi: 10.1016/s0140-6736(72)92904-2. [DOI] [PubMed] [Google Scholar]
  24. Miyasaka N., Sauvezie B., Pierce D. A., Daniels T. E., Talal N. Decreased autologous mixed lymphocyte reaction in Sjögren's syndrome. J Clin Invest. 1980 Nov;66(5):928–933. doi: 10.1172/JCI109960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nonomura A., Shintani T., Ohta G. Lymphocyte cytotoxicity to cultured rat liver cells in patients with chronic liver diseases. Tohoku J Exp Med. 1978 Oct;126(2):159–171. doi: 10.1620/tjem.126.159. [DOI] [PubMed] [Google Scholar]
  26. Opelz G., Kiuchi M., Takasugi M., Terasaki P. I. Autologous stimulation of human lymphocyte subpopulation. J Exp Med. 1975 Nov 1;142(5):1327–1333. doi: 10.1084/jem.142.5.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Paronetto F., Vernace S. Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture. Clin Exp Immunol. 1975 Jan;19(1):99–104. [PMC free article] [PubMed] [Google Scholar]
  28. Rose N. R. Autoimmunity revisited. Nature. 1978 Sep 14;275(5676):88–90. doi: 10.1038/275088a0. [DOI] [PubMed] [Google Scholar]
  29. Rössler R., Havemann K., Dölle W. Unterschiedliche Reaktion von Lymphocyten auf Phythämagglutinin (PHA) bei Lebererkrankungen. Klin Wochenschr. 1969 Aug 1;47(15):803–806. doi: 10.1007/BF01882306. [DOI] [PubMed] [Google Scholar]
  30. Sagawa A., Abdou N. I. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction. J Clin Invest. 1979 Mar;63(3):536–539. doi: 10.1172/JCI109333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sakane T., Green I. Specificity and suppressor function of human T cells responsive to autologous non-T cells. J Immunol. 1979 Aug;123(2):584–589. [PubMed] [Google Scholar]
  32. Sakane T., Steinberg A. D., Green I. Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3464–3468. doi: 10.1073/pnas.75.7.3464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Siegal F. P., Siegal M., Good R. A. Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients. J Clin Invest. 1976 Jul;58(1):109–122. doi: 10.1172/JCI108439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Smith J. B., Pasternak R. D. Syngeneic mixed lymphocyte reaction in mice: strain distribution, kinetics, participating cells, and absence in NZB mice. J Immunol. 1978 Nov;121(5):1889–1892. [PubMed] [Google Scholar]
  35. Strelkauskas A. J., Callery R. T., McDowell J., Borel Y., Schlossman S. F. Direct evidence for loss of human suppressor cells during active autoimmune disease. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5150–5154. doi: 10.1073/pnas.75.10.5150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Thomas H. C., Freni M., Sanchez-Tapias J., de Villiers D., Jain S., Sherlock S. Peripheral blood lymphocyte populations in chronic liver disease. Clin Exp Immunol. 1976 Nov;26(2):222–227. [PMC free article] [PubMed] [Google Scholar]
  37. Toh B. H., Roberts-Thomson I. C., Mathews J. D., Whittingham S., Mackay I. R. Depression of cell-mediated immunity in old age and the immunopathic diseases, lupus erythematosus, chronic hepatitis and rheumatoid arthritis. Clin Exp Immunol. 1973 Jun;14(2):193–202. [PMC free article] [PubMed] [Google Scholar]
  38. Vergani G. M., Vergani D., Jenkins P. J., Portmann B., Mowat A. P., Eddleston A. L., Williams R. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. Clin Exp Immunol. 1979 Oct;38(1):16–21. [PMC free article] [PubMed] [Google Scholar]
  39. Vyas G. N., Shulman N. R. Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science. 1970 Oct 16;170(3955):332–333. doi: 10.1126/science.170.3955.332. [DOI] [PubMed] [Google Scholar]
  40. Wands K. R., Isselbacher K. J. Lymphocyte cytotoxicity to autologous liver cells in chronic active hepatitis. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1301–1303. doi: 10.1073/pnas.72.4.1301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Williams R. C., Jr, Strickland R. G., Montaño J. D. Subpopulations of T cells (T gamma and T mu) in patients with chronic liver disease. Clin Immunol Immunopathol. 1980 Apr;15(4):616–621. doi: 10.1016/0090-1229(80)90005-7. [DOI] [PubMed] [Google Scholar]
  42. von Meyer zum Büschenfelde K. H., Knolle J., Berger J. Celluläre Immunreaktionen gegenüber homologen leberspezifischen Antigenen (HLP) bei chronischen Leberentzündungen. Klin Wochenschr. 1974 Mar 1;52(5):246–248. doi: 10.1007/BF01468598. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES